Drugs Made In America Acquisition DMII Cash Flow Statement (2024-2026)

NASDAQ DMII
$10.19 -0.01 (-0.10%)
At close: Oct 23, 2026 · 4:00 PM EDT
Reported Financials

Drugs Made In America Acquisition Quarterly Cash Flow Statement

Periods 5 quarters
Latest Jun 2026

Drugs Made In America Acquisition cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 5 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income -0.04M-0.05M4.33M4.40M
Change in Working Capital
Change in Account PayablesChange Payables 0.00M0.09M
Change in Accrued ExpensesChange Accrued Exp. 0.08M
Change in Other Operating AssetsOther Assets Change 0.57M0.81M
Other Working Capital ChangesOther WC Changes -0.57M-0.81M
Cash from OperationsCash from Ops. -0.69M-0.31M
Additional items
Change in Cash 0.31M-0.31M
Ending Cash Balance 0.02M0.32M223.00
Free Cash FlowFCF -0.69M-0.31M
Net Cash FlowNCF -0.69M-0.31M

Drugs Made In America Acquisition Cash Flow Statement API

Pull Drugs Made In America Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DMII&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY